About
Drug Delivery Technology
Areas of Focus
Categories
Drug Delivery & Formulation
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
920
By Phase
PHASE2/PHASE3: 2PHASE2: 5PHASE1: 1
By Status
COMPLETED: 5TERMINATED: 3
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05116813Lead Sponsor
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
PHASE2/PHASE3Terminated
17 participants
Started: Oct 25, 2021 · Completed: Aug 15, 2022
NCT05027997Lead Sponsor
Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm
PHASE2Completed
15 participants
Started: Oct 6, 2021 · Completed: Nov 27, 2022
NCT04857359Lead Sponsor
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
PHASE2/PHASE3Terminated
25 participants
Started: Aug 6, 2021 · Completed: Aug 15, 2022
NCT02447640Collaborator
PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration
PHASE1Completed
12 participants
Started: Apr 30, 2015 · Completed: Dec 31, 2017
NCT01336088Lead Sponsor
ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
PHASE2Completed
83 participants
Started: Apr 30, 2011 · Completed: Feb 29, 2012
Locations (1)
Headquarters
Chenôve, France
Map
Loading map...